Cover Image
Market Research Report

Breast Imaging Market - Growth, Trends, and Forecasts (2020 - 2025)

Published by Mordor Intelligence LLP Product code 661006
Published Content info 115 Pages
Delivery time: 2-3 business days
Price
Back to Top
Breast Imaging Market - Growth, Trends, and Forecasts (2020 - 2025)
Published: June 1, 2020 Content info: 115 Pages
Description

Breast Imaging market is primarily driven by the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. According to Breast Cancer Care WA, it is estimated that in 2019, 19,371 Australian women were diagnosed with breast cancer or approximately 53 each day, which accounts for approximately 14% of all new cancer cases diagnosed in 2019. On the other hand, in breast imaging procedures the subject or patient is exposed to multiple sets of radiations for therapeutic purposes. However, radiation therapy is not always good for the patient's health. Hence, the errors and side effects associated with breast screening is a major restraining factor for the growth of the market studied.

Key Market Trends

Mammography holds the major share in Global Breast Imaging Market

  • The mammography segment of the global breast imaging market is growing due to the many initiatives taken for the early detection of breast cancer. For instance, the United States Preventive Services Task Force has developed guidelines for mammography screening.
  • Additionally, the National Cancer Institute conducts and facilitates many organizations to develop their guidelines. Breast cancer is one of the leading causes of death among women. Since mammography is the standard technique used to screen breast cancer, governments and other healthcare organizations around the world are taking initiatives to provide women, between the ages of 50 and 75, access to mammography screening. This is increasing the global demand for mammography.
  • In addition, there have been a number of advancements in the field that prevent over-diagnosis and provide better sensitivity to detect smaller carcinomas. These continuous advancements in this field are expected to augment the mammography segment of global breast cancer screening tests market.

North America Accounts for the Largest Share in Global Breast Imaging Market

The number of cancer patients in North America has witnessed a considerable rise. Prostate and breast cancer are the most prevalent forms of cancer in the region. According to BreastCancer.org, as of January 2019, there were more than 3.1 million women with a history of breast cancer in the United States and the death rates were higher for breast cancer than any other cancer.

The American Cancer Society is playing a vital role in early research to demonstrate the feasibility of mass screening for breast cancer, joining hands with the National Cancer Institute on the nationwide Breast Cancer Detection Demonstration Project. There are initiatives, such as the United States Preventive Services Task Force (USPSTF), made up of doctors and specialists who are researching ways to prevent diseases or detect them early. These societies are spreading awareness among people regarding the benefits of early breast cancer diagnosis and treatment. These factors, as well as the growing innovations in breast cancer imaging techniques, are expected to drive the global breast imaging market.

Competitive Landscape

Breast Imaging Market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products and reducing the side effects of the procedures. Key players present in the market include Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., General Medical Merate SpA, Koninklijke Philips NV among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Table of Contents
Product Code: 48382

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Breast Cancer
    • 4.2.2 Technological Advancements in the Field of Breast Imaging
    • 4.2.3 Investments and Initiatives from Various Organizations in Breast Cancer Screening Campaigns
  • 4.3 Market Restraints
    • 4.3.1 Risk of Adverse Effects from Radiation Exposure
    • 4.3.2 High Cost of Imaging Systems
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type of Imaging Technique
    • 5.1.1 Mammography
    • 5.1.2 Breast Ultrasound
    • 5.1.3 Breast MRI
    • 5.1.4 Positron Emission Mammography
    • 5.1.5 Image-guided breast biopsy
    • 5.1.6 Other Imaging Techniques
  • 5.2 By End Users
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Centers
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Fujifilm Holdings Corporation
    • 6.1.2 GE Healthcare
    • 6.1.3 Hologic Inc.
    • 6.1.4 General Medical Merate S.p.A.
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 Aurora Health Care
    • 6.1.7 Canon Inc.
    • 6.1.8 CMR Naviscan Corporation
    • 6.1.9 SonoCine, Inc.
    • 6.1.10 Siemens Healthineers
    • 6.1.11 Dilon Technologies, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top